For several weeks now, health organizations in Europe have been denouncing a clear correlation between people who were inoculated with the AstraZeneca vaccine and then suffered rare blood clots that in many cases ended in the death of the patient. 

So far, the European Medicines Agency (EMA) had not confirmed the correlation, but now a senior official of the agency, Marco Cavaleri, has done so.

Marco Cavaleri, chairman of the EMA’s vaccine evaluation team, confirmed to the newspaper Il Messaggero when asked about the possible link between the AstraZeneca injection and the cases of blood clots in the brain, that: “In my opinion, we can now say it, it is clear that there is an association with the vaccine. However, we still don’t know what causes this reaction,” Reuters reported.

The vaccine expert explained that among those vaccinated with AstraZeneca, there is “a higher than expected number of cases of cerebral thrombosis with platelet deficiency among young people.” He also points out that young women are “protagonists of thrombosis cases.”

Also, Cavaleri implied that the EMA in the coming hours would admit that the “connection is there,” but it is still necessary to understand “how it happens” and “what causes that reaction.”

Following Cavaleri’s public comments, the EMA said in a statement that it was currently conducting a review of the vaccine and expected to announce its findings on Wednesday or Thursday officially.

Previously, the EMA has repeatedly said that AstraZeneca’s injection benefits outweigh the risks and therefore recommended continuing vaccination campaigns despite dozens of deaths caused by blood clots.

Without going any further, last week, the EMA said that its review had not currently identified any specific risk factors, such as age, sex, or a previous medical history of clotting disorders, for these very rare events. A causal link to the vaccine has not been proven, but it is possible, and further analysis is ongoing, the agency said.

Several countries have discontinued the AstraZeneca vaccine for recording severe adverse effects in a high percentage of inoculated patients. Denmark, Iceland, Norway, Bulgaria, and Thailand were among them. France, Italy, and Germany also momentarily suspended vaccination campaigns with AstraZeneca, although after receiving assurances from the EMA and the World Health Organization (WHO), they decided to continue.

Last week, alarm bells rang again when the German Department of Health reported at least 21 cases of blood clots in people who recently received the vaccine against the CCP Virus from AstraZeneca.

According to Germany’s federal medical regulatory agency, of the 21 people who reported blood clots associated with the AstraZeneca vaccine, seven reportedly died as a direct result, the Daily Caller reported.

While the EMA and WHO have assessed AstraZeneca’s vaccine as safe and several European Union countries have resumed vaccination, several countries such as Denmark, Iceland, Bulgaria, Luxembourg, Estonia, Lithuania, and Latvia are still awaiting their own investigations and more than a few experts believe that vaccination with AstraZeneca has come to an end.